People with multiple sclerosis (MS) and other conditions who use Mallinckrodt‘s treatment Acthar Gel(repository corticotropin injection) now have a self-injection option, the company said.
Acthar Gel Single-Dose Pre-filled SelfJect is available in two dosages — 40 USP units/0.5 ml and 80 USP units/1.0 mL — that patients can give themselves subcutaneously (under the skin) by pressing a handle. The treatment had been available only in a multi-dose, vial-and-syringe package that required patients or their caregivers to draw precise amounts of the medication before administering it.
Read full story HERE...